Galectin Therapeutics (GALT) EPS (Basic) (2010 - 2026)
Galectin Therapeutics (GALT) posted quarterly EPS (Basic) of -$0.08 for Q1 2026, up 49.31% year-over-year from -$0.05 in Q1 2025, and up 11.5% quarter-over-quarter from -$0.09 in Q4 2025.
Powered by 
Analysis
Galectin Therapeutics (GALT) EPS (Basic) (2010 - 2026) Analysis & Trends
Galectin Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.08 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 49.31% year-over-year to -$0.08; the TTM figure through Mar 2026 stood at -$0.4 (up 43.94% YoY), while the FY2025 annual figure was -$0.48, up 36.01% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.08, up from -$0.09 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.08 in Q1 2026, with the low at -$0.24 in Q3 2023.
- The 5-year median for EPS (Basic) is -$0.17 (2022), against an average of -$0.16.
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) tumbled 62.78% in 2023, then jumped 54.92% in 2025.
- Galectin Therapeutics' EPS (Basic) stood at -$0.18 in 2022, then advanced by 7.17% to -$0.17 in 2023, then declined by 15.46% to -$0.19 in 2024, then surged by 54.92% to -$0.09 in 2025, then increased by 11.5% to -$0.08 in 2026.
- Business Quant data shows GALT's EPS (Basic) at -$0.08 in Q1 2026, -$0.09 in Q4 2025, and -$0.13 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Galectin Therapeutics | 303.68 Mn | 303.68 Mn | - | -0.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.14 |
| Mar 31, 2026 | -0.08 |
| Dec 31, 2025 | -0.09 |
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | -0.12 |
| Mar 31, 2025 | -0.15 |
| Dec 31, 2024 | -0.19 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | -0.19 |
| Dec 31, 2023 | -0.17 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.15 |
| Mar 31, 2023 | -0.19 |
| Dec 31, 2022 | -0.18 |
| Sep 30, 2022 | -0.14 |
| Jun 30, 2022 | -0.16 |
| Mar 31, 2022 | -0.17 |
| Dec 31, 2021 | -0.12 |
| Sep 30, 2021 | -0.14 |